Antiestrogens specifically up-regulate bone morphogenetic protein-4 promoter activity in human osteoblastic cells

Molecular Endocrinology

Volumn 14, Issue 5, 2000, Pages 623-633

  Van Den Wijngaard, A ^a   Mulder, W R ^b   Dijkema, R ^b   Boersma, C J C ^a,b   Mosselman, S ^b   Van Zoelen, E J J ^a   Olijve, W ^a,b  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b NV ORGANON   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; BONE MORPHOGENETIC PROTEIN 4; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; STEROID HORMONE;

AMINO ACID SEQUENCE; ARTICLE; CONSENSUS SEQUENCE; DRUG ACTIVITY; DRUG EFFECT; DRUG SPECIFICITY; ESTROGEN RESPONSIVE ELEMENT; GENETIC TRANSFECTION; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOPOROSIS; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS;

EID: 0034463088     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.14.5.0463     Document Type: Article

References (53)

1. The prevention and treatment of osteoporosis
2. Cytokines and estrogen in bone: Anti-osteoporotic effects
3. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women
4. Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats
5. Analysis of the molecular pharmacology of estrogen receptor agonists and antagonists provides insights into the mechanism of action of estrogen in bone
6. Novel regulators of bone formation: Molecular clones and activities
7. Bone morphogenetic proteins: Multi-functional regulators of vertebrate development
8. Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing
9. Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing
10. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes
11. Osteoporosis: A bone morphogenetic protein auto-immune disorder
12. Bone morphogenetic proteins (BMPs): Therapeutic potential in healing bony defects
13. Genomic organization of the human bone morphogenetic protein-4 gene: Molecular basis for multiple transcripts
14. The mouse bone morphogenetic protein-4 gene. Analysis of promoter utilization in fetal rat calvarial osteoblasts and regulation by COUP-TFI orphan receptor
15. Functional characterization of two promoters in the human bone morphogenetic protein-4 gene
16. Identification of an estrogen responsive element activated by metabolites of 17 beta-estradiol and raloxifene
17. Correction: Raloxifene response needs more than an element
18. Expression of bone morphogenetic proteins by osteoinductive and non-osteoinductive human osteosarcoma cells
19. Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex
20. Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line
21. Glucocorticoid and progestin receptors are differently involved in the cooperation with a structural element of the mouse mammary tumor virus promoter
22. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens
23. Estrogen receptor ligands modulate its interaction with DNA
24. Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells. I. MCF-7 cell lines
25. Human endometrial epithelial cell lines for studying steroid and cytokine actions
26. Regulation of Msx-1, Msx-2, Bmp-2 and Bmp-4 during foetal and postnatal mammary gland development
27. Transcriptional regulation of the mBMP-4 gene through an E-box in the 5′-flanking promoter region involving USF
28. ER β: Identification and characterization of a novel human estrogen receptor
29. Estrogen receptors α and β form heterodimers on DNA
30. Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with the estrogen receptor α
31. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair
32. Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: Effects of raloxifene-HCI, tamoxifen, estrogen and aledronate
33. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells
34. Evidence of estrogen receptors in normal human osteoblast-like cells
35. Molecular basis of agonism and antagonism in the estrogen receptor
36. Coactivator and repressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen
37. Analysis of human breast cancer nuclear proteins binding to the promoter elements of the c-myc gene
38. The quinone reductase gene: A unique estrogen receptor -regulated gene that is activated by antiestrogens
39. Regulation of the transforming growth factor-β 1 and -β 3 promoters by transcription factor Sp1
40. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: Role of estrogen receptor Sp1 complex formation
41. Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells
42. Functional synergy between the transcription factor Sp1 and the estrogen receptor
43. Estrogen induces adenosine deaminase gene expression in MCF-7 human breast cancer cells: Role of estrogen receptor-Sp1 interactions
44. Tissue-selective actions of estrogen analogs
45. Cross-inhibition of both estrogen receptor α and β pathways by each dominant negative mutant
46. Differential expression of estrogen receptors α and β mRNA during differentiation of human osteoblast SV-HFO cells
47. Reporter constructs with low background activity utilizing the cat gene
48. Luciferase reporter gene vectors for analysis of promoters and enhancers
49. Sequence and expression of human estrogen receptor complementary DNA
50. The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties
51. Genomic organization, coding sequence and functional expression of human 5- HT 2 and 5-HT1A receptor genes
52. Rapid detection of octamer binding proteins with 'mini-extracts'